title: Retraction Note to: Structure-based development and optimization of therapy antibody drugs against TNFα.
authors.affiliation: Key Laboratory of Oncology, Cancer Center, Chinese PLA General Hospital and Chinese PLA Medical School, Beijing, People's Republic of China.|Translational Medicine Research Institute and International Joint Cancer Institute, The Second Military Medical University, Shanghai, People's Republic of China.|Tianjin Joint Academy of Biomedicine and Technology, Tianjin, 300457, People's Republic of China.
authors.forename: Wenyan
authors.initials: W
authors.lastname: Fu
authors.affiliation: Graduate School of Medicine, Nagoya University, Showa-ku, Nagoya, Japan.|School of Medicine, Nankai University, Tianjin, People's Republic of China.
authors.forename: Xiaoze
authors.initials: X
authors.lastname: Wang
authors.affiliation: School of Medicine, Nankai University, Tianjin, People's Republic of China.
authors.forename: Weili
authors.initials: W
authors.lastname: Yang
authors.affiliation: Tianjin Joint Academy of Biomedicine and Technology, Tianjin, 300457, People's Republic of China.|Department of Biomedicine, Nagoya University, Showa-ku, Nagoya, Japan.
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Takeda
authors.affiliation: Key Laboratory of Oncology, Cancer Center, Chinese PLA General Hospital and Chinese PLA Medical School, Beijing, People's Republic of China.|Translational Medicine Research Institute and International Joint Cancer Institute, The Second Military Medical University, Shanghai, People's Republic of China.
authors.forename: Shi
authors.initials: S
authors.lastname: Hu
authors.affiliation: Laboratory of Structural Biology and MOE Laboratory of Protein Science, School of Medicine, Tsinghua University, Beijing, People's Republic of China.
authors.forename: Zhiyong
authors.initials: Z
authors.lastname: Lou
authors.affiliation: Key Laboratory of Oncology, Cancer Center, Chinese PLA General Hospital and Chinese PLA Medical School, Beijing, People's Republic of China.|Translational Medicine Research Institute and International Joint Cancer Institute, The Second Military Medical University, Shanghai, People's Republic of China.
authors.forename: Jian
authors.initials: J
authors.lastname: Zhao
authors.affiliation: Tianjin Joint Academy of Biomedicine and Technology, Tianjin, 300457, People's Republic of China. augus.bethune@aftertumor.com.|Molecular Drug Discovery Center, Xi'an Jinwa Pharmaceutical Co., Ltd, Xi'an, 710000, Shaanxi, People's Republic of China. augus.bethune@aftertumor.com.
authors.forename: Augus N
authors.initials: AN
authors.lastname: Bethune
authors.affiliation: Key Laboratory of Oncology, Cancer Center, Chinese PLA General Hospital and Chinese PLA Medical School, Beijing, People's Republic of China. yjguo_smmu@163.com.|Translational Medicine Research Institute and International Joint Cancer Institute, The Second Military Medical University, Shanghai, People's Republic of China. yjguo_smmu@163.com.|School of Medicine, Nankai University, Tianjin, People's Republic of China. yjguo_smmu@163.com.
authors.forename: Yajun
authors.initials: Y
authors.lastname: Guo